| Metastatic Cancer Research |
H.R. 4432 HAC-D Report for FY 2022 177-88, Pg. 333-334 |
5/18/2023 |
| Addressing Health Barriers to Military Service |
H.R. 4432 HAC-D Report for FY 2022 117-88, Pg. 338 |
5/18/2023 |
| DOD Controlled Access to Health Information |
H.R. 2471 Consolidated Approps for FY 2022, JES 117- 35, Pg. 148. DOD Approps SAC-D for FY 2022 Report, Pg. 220 |
4/26/2023 |
| TRICARE Comprehensive Autism Care Demonstration Program |
S. 2943 SASC Report for FY 2017, 114-255, Pg. 205 |
4/26/2023 |
| Temporary Exemption for USUHS from Certain Paperwork Reduction Act Requirements |
H.R. 6395 NDAA for FY 2021 Sec. 716
|
4/26/2023 |
| Pilot Program on Health Care Assistance System |
S. 1605 NDAA Conference Report for FY 2022, 117-21, Section 705. H.R. 2810 NDAA for FY 2018, Section 731(d) |
4/18/2023 |
| TBI/PH |
H.R. 133 Consolidated Approps for FY 2021, JES 116-68, Pg. 154. DOD Approps for FY 2021 SAC-D Report, Pg. 235-236 |
4/11/2023 |
| EHR |
JES, DOD Approps for FY 2023, Pg. 111 & H.R. 8236 DOD Approps for FY 2023 HAC-D Report, 117-388, Pg. 260-261 |
4/6/2023 |
| Ocular Trauma Specialized Care |
H.R. 117–118, pages 180-181, accompanying H.R. 4350, the NDAA for FY 2022 |
2/21/2023 |
| Extra Medical Maternal Health Providers Demonstration Project |
H.R. 6395 NDAA for FY 2021 Sec. 746(f)(2)
|
2/14/2023 |
| Perfluorinated Chemicals (PFCs) Contamination and First Responder Exposure |
H.R. 4432 HAC-D Report for FY 2022 117-88 Pg. 65
|
2/14/2023 |
| Army Corps of Engineers Projects within the Defense Health Agency |
H.R. 1625 DoD Approps Act FY 2018 Joint Explanatory Statement Pg. 998
|
2/9/2023 |
| Study on the Incidence of Cancer Diagnosis and Mortality among Military Aviators and Aviation Support Personnel |
H.R. 6395 NDAA for FY 2021 Sec. 750
|
2/9/2023 |
| Orthotics and Prosthetics Outcomes Research |
H.R. 133 Consolidated Approps for FY 2021 JES 116-68 Pg. 154
|
2/8/2023 |
| Peer-Reviewed Cancer Research Programs |
H.R. 7617 HAC-D Report for FY 2021 116-453 Pg. 333
|
2/8/2023 |
| Adverse Events Reported for Dietary Supplements |
H.R. 4350, HASC Report for FY 2022, 117-118, Pg. 169
|
1/13/2023 |
| Anomalous Health Incidents/Havana Syndrome |
H.R. 4432, HAC-D Report for FY 2022, 117-88, Pg. 9
|
1/13/2023 |